Logo image of AL2SI.PA

2CRSI SA (AL2SI.PA) Stock Fundamental Analysis

EPA:AL2SI - Euronext Paris - Matif - FR0013341781 - Common Stock - Currency: EUR

6.06  -0.09 (-1.46%)

Fundamental Rating

3

Taking everything into account, AL2SI scores 3 out of 10 in our fundamental rating. AL2SI was compared to 26 industry peers in the Technology Hardware, Storage & Peripherals industry. The financial health of AL2SI is average, but there are quite some concerns on its profitability. AL2SI has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

AL2SI had negative earnings in the past year.
AL2SI had negative earnings in each of the past 5 years.
In multiple years AL2SI reported negative operating cash flow during the last 5 years.
AL2SI.PA Yearly Net Income VS EBIT VS OCF VS FCFAL2SI.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 0 5M -5M 10M -10M

1.2 Ratios

The Return On Assets of AL2SI (-8.34%) is worse than 76.92% of its industry peers.
AL2SI has a Return On Equity of -23.59%. This is in the lower half of the industry: AL2SI underperforms 69.23% of its industry peers.
Industry RankSector Rank
ROA -8.34%
ROE -23.59%
ROIC N/A
ROA(3y)-6%
ROA(5y)-4.94%
ROE(3y)-24.19%
ROE(5y)-19.4%
ROIC(3y)N/A
ROIC(5y)N/A
AL2SI.PA Yearly ROA, ROE, ROICAL2SI.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 0 -10 -20 -30 -40

1.3 Margins

With an excellent Gross Margin value of 95.25%, AL2SI belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
AL2SI's Gross Margin has been stable in the last couple of years.
AL2SI does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 95.25%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.01%
GM growth 5YN/A
AL2SI.PA Yearly Profit, Operating, Gross MarginsAL2SI.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 0 20 40 60 80

More info and screens

4

2. Health

2.1 Basic Checks

AL2SI does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, AL2SI has more shares outstanding
AL2SI has a better debt/assets ratio than last year.
AL2SI.PA Yearly Shares OutstandingAL2SI.PA Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 5M 10M 15M 20M
AL2SI.PA Yearly Total Debt VS Total AssetsAL2SI.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 50M 100M 150M

2.2 Solvency

An Altman-Z score of 3.90 indicates that AL2SI is not in any danger for bankruptcy at the moment.
With a decent Altman-Z score value of 3.90, AL2SI is doing good in the industry, outperforming 76.92% of the companies in the same industry.
AL2SI has a Debt/Equity ratio of 0.39. This is a healthy value indicating a solid balance between debt and equity.
AL2SI has a Debt to Equity ratio of 0.39. This is comparable to the rest of the industry: AL2SI outperforms 57.69% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.39
Debt/FCF N/A
Altman-Z 3.9
ROIC/WACCN/A
WACC7.14%
AL2SI.PA Yearly LT Debt VS Equity VS FCFAL2SI.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 0 10M 20M 30M 40M

2.3 Liquidity

AL2SI has a Current Ratio of 1.69. This is a normal value and indicates that AL2SI is financially healthy and should not expect problems in meeting its short term obligations.
AL2SI has a Current ratio (1.69) which is in line with its industry peers.
AL2SI has a Quick Ratio of 1.08. This is a normal value and indicates that AL2SI is financially healthy and should not expect problems in meeting its short term obligations.
With a Quick ratio value of 1.08, AL2SI perfoms like the industry average, outperforming 53.85% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.69
Quick Ratio 1.08
AL2SI.PA Yearly Current Assets VS Current LiabilitesAL2SI.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

More info and screens

4

3. Growth

3.1 Past

AL2SI shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 64.98%, which is quite impressive.
The Revenue has decreased by -2.51% in the past year.
Measured over the past years, AL2SI shows a small growth in Revenue. The Revenue has been growing by 3.08% on average per year.
EPS 1Y (TTM)64.98%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%192.84%
Revenue 1Y (TTM)-2.51%
Revenue growth 3Y3.08%
Revenue growth 5YN/A
Sales Q2Q%85.45%

3.2 Future

AL2SI is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 244.88% yearly.
The Revenue is expected to grow by 14.16% on average over the next years. This is quite good.
EPS Next Y1800%
EPS Next 2Y430.2%
EPS Next 3Y244.88%
EPS Next 5YN/A
Revenue Next Year9.73%
Revenue Next 2Y20.47%
Revenue Next 3Y22.62%
Revenue Next 5Y14.16%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
AL2SI.PA Yearly Revenue VS EstimatesAL2SI.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 100M 200M 300M 400M
AL2SI.PA Yearly EPS VS EstimatesAL2SI.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2023 2024 2025 2026 2027 0 0.5 1

More info and screens

4

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for AL2SI. In the last year negative earnings were reported.
AL2SI is valuated cheaply with a Price/Forward Earnings ratio of 6.98.
Based on the Price/Forward Earnings ratio, AL2SI is valued cheaper than 84.62% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of AL2SI to the average of the S&P500 Index (22.17), we can say AL2SI is valued rather cheaply.
Industry RankSector Rank
PE N/A
Fwd PE 6.98
AL2SI.PA Price Earnings VS Forward Price EarningsAL2SI.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 50 100

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of AL2SI indicates a slightly more expensive valuation: AL2SI is more expensive than 69.23% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 58.03
AL2SI.PA Per share dataAL2SI.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6 8

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as AL2SI's earnings are expected to grow with 244.88% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y430.2%
EPS Next 3Y244.88%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for AL2SI!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

2CRSI SA

EPA:AL2SI (6/2/2025, 7:00:00 PM)

6.06

-0.09 (-1.46%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryTechnology Hardware, Storage & Peripherals
Earnings (Last)04-01 2025-04-01/amc
Earnings (Next)N/A N/A
Inst Owners9.37%
Inst Owner ChangeN/A
Ins Owners55.49%
Ins Owner ChangeN/A
Market Cap135.20M
Analysts85.45
Price Target7.85 (29.54%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-7.6%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-1.16%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-20.22%
Revenue NY rev (3m)-20.22%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 6.98
P/S 0.76
P/FCF N/A
P/OCF N/A
P/B 4.73
P/tB 5.94
EV/EBITDA 58.03
EPS(TTM)-0.3
EYN/A
EPS(NY)0.87
Fwd EY14.33%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS8.02
BVpS1.28
TBVpS1.02
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -8.34%
ROE -23.59%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 95.25%
FCFM N/A
ROA(3y)-6%
ROA(5y)-4.94%
ROE(3y)-24.19%
ROE(5y)-19.4%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.01%
GM growth 5YN/A
F-ScoreN/A
Asset Turnover2.21
Health
Industry RankSector Rank
Debt/Equity 0.39
Debt/FCF N/A
Debt/EBITDA 4.36
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.69
Quick Ratio 1.08
Altman-Z 3.9
F-ScoreN/A
WACC7.14%
ROIC/WACCN/A
Cap/Depr(3y)93.52%
Cap/Depr(5y)80.3%
Cap/Sales(3y)1.3%
Cap/Sales(5y)2.22%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)64.98%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%192.84%
EPS Next Y1800%
EPS Next 2Y430.2%
EPS Next 3Y244.88%
EPS Next 5YN/A
Revenue 1Y (TTM)-2.51%
Revenue growth 3Y3.08%
Revenue growth 5YN/A
Sales Q2Q%85.45%
Revenue Next Year9.73%
Revenue Next 2Y20.47%
Revenue Next 3Y22.62%
Revenue Next 5Y14.16%
EBIT growth 1Y76.75%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year343.64%
EBIT Next 3Y95.54%
EBIT Next 5Y51.49%
FCF growth 1Y-158.31%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-126.1%
OCF growth 3YN/A
OCF growth 5YN/A